Immune cells in graft-versus-host disease
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at special immune cells in the body that may be involved in graft-versus-host disease (GVHD), a complication after a stem cell transplant. The goal is to better understand these cells to improve future treatments for GVHD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 16 and 65 years old.
- You must have been diagnosed with GVHD for the first time or are currently being treated for GVHD.
- You cannot have a history of other cancers.
- You cannot have HIV, hepatitis C, or uncontrolled hepatitis B.
- You cannot have other autoimmune diseases.
- You must be willing and able to follow the study instructions and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an experimental cell therapy called iMSC can help prevent graft-versus-host disease (a common complication after a stem cell transplant). It is given soon after your transplant, within 5 days of enrolling, and aims to reduce the chance of this serious condition.
This study is testing whether the timing of a stem cell infusion affects the chance of developing graft-versus-host disease (aGVHD), a common complication after transplant. It may help make transplants safer for people with blood cancers.
This trial tests two different medicines to prevent graft-versus-host disease (a condition where donor cells attack your body) after a donor lymphocyte infusion. The goal is to make the treatment safer and more effective for patients whose blood cancer has returned after a transplant.
This study looks at immune cells in tissues affected by chronic graft-versus-host disease (cGVHD), a common complication after a stem cell transplant. It aims to better understand the condition, which may lead to better treatments.
This study looks at immune cells in your blood and in tissues affected by chronic graft-versus-host disease (a condition where donor cells attack your body) after a stem cell transplant. By analyzing samples, researchers hope to better understand this condition and improve future treatments.
This study looks for proteins or markers in your blood that could help predict a condition called chronic graft-versus-host disease (cGVHD), a common complication after a stem cell transplant from a donor. By joining, you may help doctors detect and treat this condition earlier.
Hear when a new Acute Graft Versus Host Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.